Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115404 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Marta Fortuny und 17 weiteren Autor:innen. Beteiligte Einrichtung: Barcelona Clinic Liver Cancer (BCLC) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; Liver Oncology Unit, Liver Uni…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Immunotherapy, Cardiovascular Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Spanish Association Against Cancer Scientific Foundation, Carlos III Health Institute.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barcelona Clinic Liver Cancer (BCLC) Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; Liver Oncology Unit, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain; Centro de Investiga…
- Servicio de Digestivo, Sección de Hepatología, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Biostatistics Unit, Medical School, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Cardiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
- Radiodiagnostic Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Liver Oncology Unit, Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Förderung
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Spanish Association Against Cancer Scientific Foundation
- Carlos III Health Institute
- Generalitat de Catalunya
- Societat Catalana de Digestologia
- Asociación Española para el Estudio del Hígado
Zitieren
APA
Fortuny, M., García-Calonge, M., Arrabal, Ó., Sanduzzi-Zamparelli, M., Castaño-García, A., Cascos, E., Mesa, A., Piedra-Cerezal, A. M., Llarch, N., Iserte, G., Campos, M., González, M., Marsal, A., Lorca, R., Rodríguez, M., Torres, F., Varela, M., & Reig, M. (2025). Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115404
Vancouver
Fortuny M, García-Calonge M, Arrabal Ó, Sanduzzi-Zamparelli M, Castaño-García A, Cascos E, et al. Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115404
BibTeX
@article{Fortuny2025,
author = {Fortuny, Marta and García-Calonge, Marta and Arrabal, Óscar and Sanduzzi-Zamparelli, Marco and Castaño-García, Andrés and Cascos, Enric and Mesa, Alicia and Piedra-Cerezal, Ana María and Llarch, Neus and Iserte, Gemma and Campos, Marta and González, Melina and Marsal, Aida and Lorca, Rebeca and Rodríguez, Manuel and Torres, Ferran and Varela, María and Reig, María},
title = {Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115404}
}
EUVIMED